TSC22D3 and inflammatory bowel disease: To investigate on the gender-specific actions of prednisone in IBD patients, we evaluated in intestinal biopsies at disease onset the levels of the GC target gene GILZ in a subgroup of 14 patients (5 females, 3 CD; Supplementary Table 1), belonging to the same cohort of patients described above; no significant difference was observed in the demographic characteristics between the whole cohort and this subgroup.